Annual EBITDA
-$2.04 M
-$1.52 M-289.94%
December 31, 2022
Summary
- As of February 10, 2025, MTRY annual EBITDA is -$2.04 million, with the most recent change of -$1.52 million (-289.94%) on December 31, 2022.
Performance
MTRY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$365.60 K
-$26.50 K-7.81%
June 30, 2023
Summary
- As of February 10, 2025, MTRY quarterly EBITDA is -$365.60 thousand, with the most recent change of -$26.50 thousand (-7.81%) on June 30, 2023.
- Over the past year, MTRY quarterly EBITDA has dropped by -$22.80 thousand (-6.65%).
Performance
MTRY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$2.03 M
-$22.80 K-1.13%
June 30, 2023
Summary
- As of February 10, 2025, MTRY TTM EBITDA is -$2.03 million, with the most recent change of -$22.80 thousand (-1.13%) on June 30, 2023.
- Over the past year, MTRY TTM EBITDA has dropped by -$797.00 thousand (-64.54%).
Performance
MTRY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MTRY EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -289.9% | -6.7% | -64.5% |
3 y3 years | - | -100.0% | -100.0% |
5 y5 years | - | -100.0% | -100.0% |
MTRY EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +289.9% | at low | +7.8% | +136.3% | +288.6% | +3.3% |
5 y | 5-year | +289.9% | at low | <-9999.0% | +136.3% | <-9999.0% | +3.3% |
alltime | all time | +289.9% | at low | <-9999.0% | +136.3% | <-9999.0% | +3.3% |
Monterey Bio Acquisition EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$365.60 K(+7.8%) | -$2.03 M(+1.1%) |
Mar 2023 | - | -$339.10 K(-26.8%) | -$2.01 M(-1.5%) |
Dec 2022 | -$2.04 M | -$463.20 K(-46.4%) | -$2.04 M(-2.8%) |
Sep 2022 | - | -$863.90 K(+152.0%) | -$2.10 M(+69.9%) |
Jun 2022 | - | -$342.80 K(-7.1%) | -$1.23 M(+38.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$369.10 K(-29.4%) | -$892.00 K(+70.6%) |
Dec 2021 | -$522.90 K | -$522.70 K(>+9900.0%) | -$522.90 K(>+9900.0%) |
Sep 2021 | - | -$200.00(<-9900.0%) | -$200.00(<-9900.0%) |
Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2021 | - | $0.00 | $0.00 |
FAQ
- What is Monterey Bio Acquisition annual EBITDA?
- What is the all time high annual EBITDA for Monterey Bio Acquisition?
- What is Monterey Bio Acquisition annual EBITDA year-on-year change?
- What is Monterey Bio Acquisition quarterly EBITDA?
- What is the all time high quarterly EBITDA for Monterey Bio Acquisition?
- What is Monterey Bio Acquisition quarterly EBITDA year-on-year change?
- What is Monterey Bio Acquisition TTM EBITDA?
- What is the all time high TTM EBITDA for Monterey Bio Acquisition?
- What is Monterey Bio Acquisition TTM EBITDA year-on-year change?
What is Monterey Bio Acquisition annual EBITDA?
The current annual EBITDA of MTRY is -$2.04 M
What is the all time high annual EBITDA for Monterey Bio Acquisition?
Monterey Bio Acquisition all-time high annual EBITDA is -$522.90 K
What is Monterey Bio Acquisition annual EBITDA year-on-year change?
Over the past year, MTRY annual EBITDA has changed by -$1.52 M (-289.94%)
What is Monterey Bio Acquisition quarterly EBITDA?
The current quarterly EBITDA of MTRY is -$365.60 K
What is the all time high quarterly EBITDA for Monterey Bio Acquisition?
Monterey Bio Acquisition all-time high quarterly EBITDA is $0.00
What is Monterey Bio Acquisition quarterly EBITDA year-on-year change?
Over the past year, MTRY quarterly EBITDA has changed by -$22.80 K (-6.65%)
What is Monterey Bio Acquisition TTM EBITDA?
The current TTM EBITDA of MTRY is -$2.03 M
What is the all time high TTM EBITDA for Monterey Bio Acquisition?
Monterey Bio Acquisition all-time high TTM EBITDA is $0.00
What is Monterey Bio Acquisition TTM EBITDA year-on-year change?
Over the past year, MTRY TTM EBITDA has changed by -$797.00 K (-64.54%)